🔗 Permalink

Assignee profile:

Avacta Life Sciences Limited

City:

Wetherby

Country:

United Kingdom

Published Applications:

Last publication date:

2025-08-28

Patent Grants:

Last grant date:

2025-04-29

Top Inventors for applications by Avacta Life Sciences Limited

These are the the leading inventors for applications assigned to Avacta Life Sciences Limited:

Estelle Adam 5 Hitchin, United Kingdom
Amrik Basran 5 Cambridge, United Kingdom
Emma Jenkins 4 Stansted, United Kingdom
Matthew P. VINCENT 4 Amesbury, MA United States

Graham Robert Pye-Smith Spence 3 Wetherby, United Kingdom
Geoffrey William Platt 3 Wetherby, United Kingdom
Emma Stanley 3 Hitchin, United Kingdom
Emma Jenkins 2 Stansted, Essex, United Kingdom

William Bachovchin 2 Melrose, MA United States
Graham Robert Pye-smith Spence 1 Wetherby, Yorkshire, United Kingdom
Amrik Basran 1 Cambridge, Cambridgeshire, United Kingdom
Bruno Gomes 1 Vila do Conde, Portugal

Paul Ko Ferrigno 1 Leeds, United Kingdom
Michelle Writer 1 Cambridge, United Kingdom
Elisenda Gendra 1 Leeds, United Kingdom
Geoff William Platt 1 Wetherby, Yorkshire, United Kingdom

Estelle Adam 1 Hitchin, Hertfordshire, United Kingdom
Michele Writer 1 Cambridge, Cambridgeshire, United Kingdom
Emma Stanley 1 Hitchin, Hertfordshire, United Kingdom

Recent patent applications by Avacta Life Sciences Limited

Avacta Life Sciences Limited based in Wetherby, GB has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-08-28

US20250270293A1

Chemistry; metallurgy

SCAFFOLD PROTEINS

#2 | 2025-07-31

US20250243277A1

Chemistry; metallurgy

PD-L1 BINDING AFFIMERS

#3 | 2024-09-26 ✅ Patent 12,286,468 granted on 2025-04-29

US20240317839A1

Chemistry; metallurgy

Scaffold proteins

#4 | 2023-12-07

US20230390409A1

Human necessities

FAP-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES

#5 | 2023-11-30

US20230381330A1

Human necessities

ENZYME-ACTIVATED SERUM EXTENDED HALF-LIFE THERAPEUTIC CONJUGATES

#6 | 2023-08-31

US20230272081A1

Chemistry; metallurgy

SERUM HALF-LIFE EXTENDED PD-L1 INHIBITORY POLYPEPTIDES

#7 | 2023-08-31

US20230272011A1

Chemistry; metallurgy

SERUM ALBUMIN-BINDING POLYPEPTIDES

#8 | 2021-06-03

US20210163599A1

Chemistry; metallurgy

PD-L1 BINDING AFFIMERS, AND USES RELATED THERETO

#9 | 2020-06-11 ✅ Patent 11,952,415 granted on 2024-04-09

US20200181239A1

Chemistry; metallurgy

Scaffold proteins

#10 | 2016-01-28 ✅ Patent 9,447,170 granted on 2016-09-20

US20160024184A1

Chemistry; metallurgy

Modified Stefin A scaffold proteins

Also check out AVACTA LIFE SCIENCES LIMITED's (Wetherby, United Kingdom) applicant profile with 5 patent applications submitted.

AssigneeID:

311142 ⎘